Experimental diabetes drug shows promise in Mid-Stage trial
NCT ID NCT00497198
Summary
This study tested whether a new drug called MCI-196 could help control type 2 diabetes. Researchers gave the drug or a placebo to 183 people with diabetes for 12 weeks to see if it improved their blood sugar and cholesterol levels. The study was designed to measure both effectiveness and safety of this potential new treatment option.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.